Literature DB >> 12579297

Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer.

Pia Azarschab1, Agnieszka Stembalska, Mirela Baus Loncar, Markus Pfister, Maria M Sasiadek, Nikolaus Blin.   

Abstract

Intercellular adhesion is promoted by many-fold structures formed by interacting molecules. One prominent protein family, called cadherins, consists of calcium-dependent proteins contributing to cell differentiation, migration and extracellular signal transduction. E-cadherin, regularly expressed in epithelial tissues, displays aberrant activity patterns in a variety of tumors. We have explored the mode of E-cadherin regulation in 98 biopsy samples from 76 patients with laryngeal carcinoma (80 primary tumors and 18 metastases). Transcriptional silencing of the gene (CDH1) achieved by promoter methylation was tested by a methylation-specific PCR. In primary tumors, CDH1 methylation was noted in 40%. However, 77% of the tested metastases showed CDH1 methylation, 23% remained unmethylated (p<0.01). These data suggest that the E-cadherin promoter is subjected to epigenetic control connected with biological aggressiveness of laryngeal cancer in advanced steps of neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579297

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  E-cadherin plasticity in prostate cancer stem cell invasion.

Authors:  Kyung-Mi Bae; Nicole N Parker; Yao Dai; Johannes Vieweg; Dietmar W Siemann
Journal:  Am J Cancer Res       Date:  2010-10-20       Impact factor: 6.166

2.  Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.

Authors:  Jian Yu; Hongyu Zhang; Jun Gu; Song Lin; Junhua Li; Wei Lu; Yifei Wang; Jingde Zhu
Journal:  BMC Cancer       Date:  2004-09-14       Impact factor: 4.430

3.  High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome.

Authors:  Christina Piperi; Marios S Themistocleous; George A Papavassiliou; Elena Farmaki; Georgia Levidou; Penelope Korkolopoulou; Christos Adamopoulos; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2009-10-12       Impact factor: 6.354

4.  Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy.

Authors:  Jessica Hier; Olivia Vachon; Allison Bernstein; Iman Ibrahim; Alex Mlynarek; Michael Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

5.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

6.  Epigenetic dysregulation in laryngeal squamous cell carcinoma.

Authors:  Thian-Sze Wong; Wei Gao; Zeng-Hong Li; Jimmy Yu-Wai Chan; Wai-Kuen Ho
Journal:  J Oncol       Date:  2012-05-07       Impact factor: 4.375

7.  DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells.

Authors:  Patrick R Brambert; Daniel J Kelpsch; Rabia Hameed; Charmi V Desai; Gianfranco Calafiore; Lucy A Godley; Stacey L Raimondi
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

8.  Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.

Authors:  Baoshan Wang; Lei Zhao; Weiwei Chi; Huan Cao; Weina Cui; Wenxia Meng
Journal:  Epigenetics Chromatin       Date:  2019-06-13       Impact factor: 4.954

Review 9.  Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem.

Authors:  Michela Falco; Chiara Tammaro; Takashi Takeuchi; Alessia Maria Cossu; Giuseppe Scafuro; Silvia Zappavigna; Annalisa Itro; Raffaele Addeo; Marianna Scrima; Angela Lombardi; Filippo Ricciardiello; Carlo Irace; Michele Caraglia; Gabriella Misso
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

10.  E-Cadherin, NFATC3, and PLP2 Are Differentially Methylated in Multiple Cancers.

Authors:  Mary J Lotesto; Christopher J Wallace; Stacey L Raimondi
Journal:  Epigenet Insights       Date:  2020-10-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.